Evidence map›Paper›PMID 26878192›Full record

ArticleJournal of the American Chemical Society2016

Ribosome-Templated Azide-Alkyne Cycloadditions: Synthesis of Potent Macrolide Antibiotics by In Situ Click Chemistry.

Ian Glassford, Christiana N Teijaro, Samer S Daher, Amy Weil, Meagan C Small, Shiv K Redhu, Dennis J Colussi, Marlene A Jacobson, Wayne E Childers, Bettina Buttaro and 4 more

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
7.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 64 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Sulfur fluoride exchange.Nature reviews. Methods primers · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Chemical science · 2020
    Article
  13. Article
  14. Review
  15. Protein-Catalyzed Capture Agents.Chemical reviews · 2019
    Review
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Ian GlassfordDepartment of Chemistry, Temple University , Philadelphia, Pennsylvania 19122, United States.
Christiana N TeijaroDepartment of Chemistry, Temple University , Philadelphia, Pennsylvania 19122, United States.
Samer S DaherDepartment of Chemistry, Temple University , Philadelphia, Pennsylvania 19122, United States.
Amy WeilDepartment of Chemistry, University of Pennsylvania , Philadelphia, Pennsylvania 19104, United States.
Meagan C SmallDepartment of Pharmaceutical Sciences, School of Pharmacy, University of Maryland , Baltimore, Maryland 21201, United States.
Shiv K RedhuDepartment of Biology, Temple University , Philadelphia, Pennsylvania 19122, United States.
Dennis J ColussiMoulder Center for Drug Discovery Research, Temple University School of Pharmacy , Philadelphia, Pennsylvania 19140, United States.
Marlene A JacobsonMoulder Center for Drug Discovery Research, Temple University School of Pharmacy , Philadelphia, Pennsylvania 19140, United States.
Wayne E ChildersMoulder Center for Drug Discovery Research, Temple University School of Pharmacy , Philadelphia, Pennsylvania 19140, United States.
Bettina ButtaroDepartment of Microbiology and Immunology, Temple University School of Medicine , Philadelphia, Pennsylvania 19140, United States.
Allen W NicholsonDepartment of Biology, Temple University , Philadelphia, Pennsylvania 19122, United States.
Alexander D MacKerellDepartment of Pharmaceutical Sciences, School of Pharmacy, University of Maryland , Baltimore, Maryland 21201, United States.
Barry S CoopermanDepartment of Chemistry, University of Pennsylvania , Philadelphia, Pennsylvania 19104, United States.
Rodrigo B AndradeDepartment of Chemistry, Temple University , Philadelphia, Pennsylvania 19122, United States.
Temple University · USUniversity of Maryland, Baltimore · USUniversity of Pennsylvania · US

Funding

Oligonucleotide Conformational HeterogeneityR01GM051501 · NIGMS · UNIVERSITY OF MARYLAND BALTIMORE · PI MACKERELL, ALEXANDER D · 2003 to 2018
$3.6M
Carbohydrate force fields for structure, dynamics and molecular recognitionR01GM070855 · NIGMS · UNIVERSITY OF MARYLAND BALTIMORE · PI MACKERELL, ALEXANDER D · 2005 to 2018
$3.5M
Single Molecule Dynamics of mRNA TranslationR01GM080376 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI COOPERMAN, BARRY S., GOLDMAN, YALE E · 2008 to 2016
$2.5M
Discovery of Novel Macrolide AntibioticsR01AI080968 · NIAID · TEMPLE UNIV OF THE COMMONWEALTH · PI ANDRADE, RODRIGO B · 2009 to 2012
$1.3M
HALOGEN FREE ENERGY DATABASE FOR RATIONAL DRUG DESIGNR29GM051501 · NIGMS · UNIVERSITY OF MARYLAND BALTIMORE · PI MACKERELL, ALEXANDER D. · 1996 to 2000
$108k
NIAID NIH HHS AI080968NIAID NIH HHS R01 AI080968NIGMS NIH HHS GM051501NIGMS NIH HHS GM070855NIGMS NIH HHS R01 GM051501NIGMS NIH HHS R01 GM070855NIGMS NIH HHS R01 GM080376NIGMS NIH HHS R29 GM051501
6 · The paper itself

Abstract

Over half of all antibiotics target the bacterial ribosome-nature's complex, 2.5 MDa nanomachine responsible for decoding mRNA and synthesizing proteins. Macrolide antibiotics, exemplified by erythromycin, bind the 50S subunit with nM affinity and inhibit protein synthesis by blocking the passage of nascent oligopeptides. Solithromycin (1), a third-generation semisynthetic macrolide discovered by combinatorial copper-catalyzed click chemistry, was synthesized in situ by incubating either E. coli 70S ribosomes or 50S subunits with macrolide-functionalized azide 2 and 3-ethynylaniline (3) precursors. The ribosome-templated in situ click method was expanded from a binary reaction (i.e., one azide and one alkyne) to a six-component reaction (i.e., azide 2 and five alkynes) and ultimately to a 16-component reaction (i.e., azide 2 and 15 alkynes). The extent of triazole formation correlated with ribosome affinity for the anti (1,4)-regioisomers as revealed by measured Kd values. Computational analysis using the site-identification by ligand competitive saturation (SILCS) approach indicated that the relative affinity of the ligands was associated with the alteration of macrolactone+desosamine-ribosome interactions caused by the different alkynes. Protein synthesis inhibition experiments confirmed the mechanism of action. Evaluation of the minimal inhibitory concentrations (MIC) quantified the potency of the in situ click products and demonstrated the efficacy of this method in the triaging and prioritization of potent antibiotics that target the bacterial ribosome. Cell viability assays in human fibroblasts confirmed 2 and four analogues with therapeutic indices for bactericidal activity over in vitro mammalian cytotoxicity as essentially identical to solithromycin (1).

Indexed as

AlkynesAnti-Bacterial AgentsAzidesClick ChemistryCycloaddition ReactionHumansMacrolidesModels, MolecularRibosomesThermodynamicsTriazolesAlkynesAnti-Bacterial AgentsAzidesMacrolidessolithromycinTriazoles

Identifiers

PMID26878192
PMCPMC4785600
OpenAlexW2283410385

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.